World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
82
Citations
27467
World Ranking
1047
National Ranking
479

David F. Stroncek publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where David F. Stroncek sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 536 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

David F. Stroncek D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where David F. Stroncek sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 82 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

David F. Stroncek is affiliated with the National Institutes of Health in the United States. Their research primarily spans the fields of medicine, biochemistry, genetics, and molecular biology with a significant focus on oncology, genetics, immunology, molecular biology, and hematology as subfields of study.

The scientist has concentrated work on several main topics, including CAR-T cell therapy research, viral infectious diseases and gene expression in insects, immune cell function and interaction, virus-based gene therapy research, hematopoietic stem cell transplantation, mesenchymal stem cell research, and immunotherapy and immune responses.

Among recent papers authored or coauthored by Stroncek are:

  • CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial (2020) - Journal of Clinical Oncology
  • Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL (2021) - Journal of Clinical Oncology
  • Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma (2020) - Nature Medicine
  • TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers (2021) - Nature Medicine
  • Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells (2021) - Blood

Frequent coauthors collaborating with Stroncek include:

  • Steven L. Highfill
  • Sandhya R. Panch
  • Ping Jin
  • Nirali N. Shah
  • Lipei Shao

The scientist has published extensively across several venues, with the highest number of publications appearing in:

  • Blood
  • Cytotherapy
  • Journal of Translational Medicine
  • Transplantation and Cellular Therapy
  • Transfusion

Best Publications

  • CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy.

    Terry J Fry;Nirali N Shah;Rimas J Orentas;Maryalice Stetler-Stevenson

  • Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program

    Nancy A. Kernan;Glenn Bartsch;Robert C. Ash;Patrick G. Beatty

  • Transfusion-related acute lung injury : Definition and review

    Pearl Toy;Mark A. Popovsky;Edward Abraham;Daniel R. Ambruso

  • T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma

    Syed Abbas Ali;Victoria Shi;Irina Maric;Michael Wang

  • T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

    Jennifer N. Brudno;Irina Maric;Steven D. Hartman;Jeremy J. Rose

  • NAFLD causes selective CD4 + T lymphocyte loss and promotes hepatocarcinogenesis

    Chi Ma;Aparna H. Kesarwala;Tobias Eggert;José Medina-Echeverz

  • The association of biologically active lipids with the development of transfusion‐related acute lung injury: a retrospective study

    Christopher C. Silliman;Andrew J. Paterson;William O. Dickey;David F. Stroncek

  • International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

    Jacques Galipeau;Mauro Krampera;John Barrett;Francesco Dazzi

  • Complement activation and neutropenia occurring during cardiopulmonary bypass

    Dale E. Hammerschmidt;David F. Stroncek;Timothy K. Bowers;Carol J. Lammi-Keefe

  • CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial

    Nirali N. Shah;Steven L. Highfill;Haneen Shalabi;Bonnie Yates

  • Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies.

    Marianna Sabatino;Jinhui Hu;Michele Sommariva;Michele Sommariva;Sanjivan Gautam

  • Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL.

    Nirali N Shah;Daniel W Lee;Bonnie Yates;Constance M Yuan

  • Prostaglandin E2 Enhances Human Cord Blood Stem Cell Xenotransplants and Shows Long-Term Safety in Preclinical Nonhuman Primate Transplant Models

    Wolfram Goessling;Robyn S. Allen;Xiao Guan;Ping Jin

  • Gene expression profiling of cutaneous wound healing.

    Kavita Deonarine;Monica C Panelli;Mitchell E Stashower;Ping Jin

  • Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.

    D F Stroncek;M E Clay;M L Petzoldt;J Smith

  • Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors.

    M P Busch;S H Kleinman;B Jackson;S L Stramer

  • Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

    Jennifer N Brudno;Norris Lam;Danielle Vanasse;Yueh-Wei Shen

  • TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers.

    Nisha B. Nagarsheth;Scott M. Norberg;Andrew L. Sinkoe;Sabina Adhikary

  • Allogeneic blood stem cell transplantation: considerations for donors

    Paolo Anderlini;Martin Körbling;David Dale;Alois Gratwohl

  • MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells.

    Jiaqiang Ren;Ping Jin;Ena Wang;Francesco M Marincola

  • Future perspectives in melanoma research

    Paolo A. Ascierto;Sanjiv Agarwala;Gerardo Botti;Alessandra Cesano

  • Main roads to melanoma

    Giuseppe Palmieri;Mariaelena Capone;Maria Libera Ascierto;Giusy Gentilcore

  • Adverse reactions in patients transfused with cryopreserved marrow

    D. F. Stroncek;S. K. Fautsch;L. C. Lasky;D. D. Hurd

  • Cell and gene therapies: moving from research to clinic

    David F Stroncek;Raj K Puri

Frequent Co-Authors

Francesco M. Marincola
Francesco M. Marincola National Institutes of Health
Susan F. Leitman
Susan F. Leitman National Institutes of Health
Ena Wang
Ena Wang Toro bio
Richard Childs
Richard Childs National Institutes of Health
Ronald E. Gress
Ronald E. Gress National Institutes of Health
Steven Z. Pavletic
Steven Z. Pavletic National Institutes of Health
Crystal L. Mackall
Crystal L. Mackall Stanford University
Terry J. Fry
Terry J. Fry University of Colorado Denver
Pamela Gehron Robey
Pamela Gehron Robey National Institutes of Health
James N. Kochenderfer
James N. Kochenderfer National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to varied healthcare-related careers. Beyond traditional lab roles, many graduates explore opportunities in health information management and medical coding, where their scientific background is valuable for handling clinical data.

For those interested in medical coding, obtaining a cpc certification salary and career paths provide insight into potential earnings and advancement. This certification is key for becoming a Certified Professional Coder, a role essential for accurate medical billing and compliance.

Alternatively, pursuing a degree focused on health data can lead to careers in managing patient information systems. Understanding the health information management degree salary landscape helps gauge long-term goals in this field.

When looking for quality programs, students should consider online health information management programs cahiim accredited, which ensure the education meets industry standards and supports career readiness.

For faster entry into the workforce, many choose a fast track medical billing and coding certificate online. These programs provide essential skills quickly and can complement a microbiology background for diverse career options.

Best Scientists Citing David F. Stroncek

Trending Scientists